MedPath

tility of visual inspection of the cervix in diagnosing early forms of cervical CANcer in HIV positive wome

Not Applicable
Completed
Conditions
HIV, premalignant lesion of the cervix
Cancer
Malignant neoplasm of cervix uteri
Registration Number
ISRCTN90623294
Lead Sponsor
igerian Institute of Medical Research (Nigeria)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
1000
Inclusion Criteria

1. Nigerian
2. Female
3. Aged 18 years or over
4. Known HIV status

Exclusion Criteria

1. Known reaction to Lugol's iodine
2. Refusal to do HIV test
3. Overt cancer of the cervix

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Premalignant lesion of the cervix
Secondary Outcome Measures
NameTimeMethod
High-risk HPV types
© Copyright 2025. All Rights Reserved by MedPath